Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes
Open Access
- 1 February 1993
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (2) , 187-190
- https://doi.org/10.1128/aac.37.2.187
Abstract
The penetration of fluconazole into human polymorphonuclear leukocytes (PMNs) and tissue culture epithelial cells (McCoy) was evaluated. At different extracellular concentrations (0.5 to 10 mg/liter), fluconazole reached cell-associated concentrations greater than the extracellular ones in either human PMNs (intracellular concentration to extracellular concentration ratio, > or = 2.2) or McCoy cells (intracellular concentration to extracellular concentration ratio, > or = 1.3). The uptake of fluconazole by PMNs was rapid and reversible but was not energy dependent. The intracellular penetration of fluconazole was not affected by environmental pH or temperature. Ingestion of opsonized zymosan and opsonized Candida albicans did not significantly increase the amount of PMN-associated fluconazole. At therapeutic extracellular concentrations, the intracellular activity of fluconazole against C. albicans in PMNs was significantly lower than that of amphotericin B. It was concluded that fluconazole reaches high intracellular concentrations within PMNs but shows moderate activity against intracellular C. albicans in vitro.Keywords
This publication has 13 references indexed in Scilit:
- Intracellular distribution and activity of antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Effect of amphotericin B, flnconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophagesJournal of Antimicrobial Chemotherapy, 1990
- Effects of antifungal agents on the function of human neutrophils in vitroAntimicrobial Agents and Chemotherapy, 1990
- Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytesAntimicrobial Agents and Chemotherapy, 1989
- COMPARISON OF FLUCONAZOLE AND KETOCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN AIDSThe Lancet, 1989
- Effects of azole antifungals in vitro on host/parasite interactions relevant to candida infectionsJournal of Antimicrobial Chemotherapy, 1988
- Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1986
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985
- Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicansJournal of Antimicrobial Chemotherapy, 1983